Fusion Completes Private Placement of Common Stock Led by Morgan Stanley Credit Partners
May 08, 2018 11:05 am UTC| Business
NEW YORK, May 08, 2018 -- Fusion (NASDAQ:FSNN), a leading provider of cloud services, announced today that on May 4, 2018, it closed a private placement (the “Private Placement”) of 1,523,811 shares of its common stock....
ACM Research Reports First Quarter 2018 Results
May 08, 2018 11:05 am UTC| Business
FREMONT, Calif., May 08, 2018 -- ACM Research, Inc. (“ACM Research” or the “Company”) (NASDAQ:ACMR), a provider of single-wafer wet cleaning equipment used by manufacturers of advanced semiconductors, today reported...
Atara Biotherapeutics Announces First Quarter 2018 Financial Results and Recent Operational Progress
May 08, 2018 11:05 am UTC| Business
SOUTH SAN FRANCISCO, Calif., May 08, 2018 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune...
May 08, 2018 11:05 am UTC| Business
Worldwide Ocaliva net sales of $35.2 million in the first quarter of 20182018 worldwide Ocaliva net sales currently expected to be between $170 million and $185 millionContinuing to advance leading NASH Phase 3 program:...
System-On-Chip Market to hit US$ 206.79 Billion by 2026: Transparency Market Research
May 08, 2018 11:03 am UTC| Business
ALBANY, New York, May 08, 2018 -- According to a new market report pertaining to the system-on-chip market, published by Transparency Market Research, the global system-on-chip market is expected to reach US$ 206.79 Bn...
JD.com Announces First Quarter 2018 Results
May 08, 2018 11:02 am UTC| Business
BEIJING, May 08, 2018 -- JD.com, Inc. (NASDAQ:JD), China’s leading technology driven e-commerce company and retail infrastructure service provider, today announced its unaudited financial results for the quarter ended...
ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018
May 08, 2018 11:01 am UTC| Business
Geneva, Switzerland and Boston, MA - May 8, 2018- ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that...